Edge Advisors’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Edge Advisors’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$90K	Hold	2,100	–	–	0.01%	418
2018 Q1	$87K	Hold	2,100	–	–	0.01%	433
2017 Q4	$91K	Hold	2,100	–	–	0.01%	414
2017 Q3	$89K	Hold	2,100	–	–	0.01%	405
2017 Q2	$90K	Hold	2,100	–	–	0.01%	412
2017 Q1	$87K	Hold	2,100	–	–	0.01%	433
2016 Q4	$82K	Buy	+2,100	New	+$85.5K	0.01%	410

Other funds holding XPH

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

JGGDR

JGP Global Gestao de Recursos Rio De Janeiro, Brazil $23.2M AUM 88.58% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Edge Advisors's XPH Position: Q2 2018 in Review

Edge Advisors held its State Street SPDR S&P Pharmaceuticals ETF (XPH) position steady in Q2 2018 at 2,100 shares worth $90K. The position accounts for 0.01% of the portfolio, ranked #418.

Edge Advisors first reported a position in XPH in Q4 2016 and has held it in 7 quarters since. The position peaked at $91K in Q4 2017. 70 funds tracked by Wall St. Rank hold XPH as of Q2 2018.

Edge Advisors held 2,100 shares of State Street SPDR S&P Pharmaceuticals ETF worth $90K as of Q2 2018.
Edge Advisors left its State Street SPDR S&P Pharmaceuticals ETF share count unchanged in Q2 2018.
State Street SPDR S&P Pharmaceuticals ETF made up 0.01% of Edge Advisors's portfolio in Q2 2018, its #418 holding.
Edge Advisors first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q4 2016 and has held it in 7 quarters since.
Edge Advisors's State Street SPDR S&P Pharmaceuticals ETF position peaked at $91K in Q4 2017.
70 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2018.

Based on Edge Advisors's 13F filing for Q2 2018, filed 14 Aug 2018.